Details
Guidance Document: Recording and reporting of suspicious transactions for controlled substances and precursors (CS-GD-025) - Canada.ca
Metadata and links for an archived snapshot.
- Source
- Health Canada
- Date
- Apr 19, 2025 · edition #1
- Timestamp
- 2025-04-19T00:21:56.885Z
- Language
- en
- ID
- 246088
- Status
- 200
- Type
- text/html
Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.
Other snapshots
Apr 14, 2026
hc-20260101
Apr 19, 2025
legacy-hc-2025-04-21
Apr 19, 2025
legacy-hc-2025-04-21
Apr 19, 2025 · (this snapshot)
legacy-hc-2025-04-21
